About
Cell Therapies for Ophthalmology
Areas of Focus
Categories
Stem Cell & Cellular TherapyBiotech
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
1
As Collaborator
3
Total Enrollment
121
By Phase
PHASE1: 4
By Status
RECRUITING: 2COMPLETED: 1UNKNOWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05636579Collaborator
Study to Assess Safety and Tolerability of Multiple Doses of EO2002
PHASE1Recruiting
12 participants
Started: Nov 8, 2022 · Completed: Dec 31, 2025
NCT05587205Collaborator
Study to Assess Safety and Tolerability of EO2002
PHASE1Recruiting
32 participants
Started: Aug 30, 2022 · Completed: Dec 1, 2025
NCT04894110Lead Sponsor
Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema
PHASE1Completed
42 participants
Started: Jun 22, 2021 · Completed: Oct 3, 2024
NCT04191629Collaborator
Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema
PHASE1Unknown
35 participants
Started: May 4, 2016 · Completed: Feb 28, 2021
Locations (1)
Headquarters
Menlo Park, CA, United States
Map
Loading map...